Three years to the day after the
rounded off its worst May since 1940
, blue chips jumped by triple digits to hit yet another historic
high. (Back then, Korea concerns and European angst dominated
discussions, but now thankfully neither
is an issue.)
Wedding ring king
) surged 3.95% to a fresh 52-week peak. Indeed romance was
everywhere in the air, even if Shakespeare surely didn't have Larry
in mind when he wrote the heartfelt lines: "Shall I
compare thee to a Summer's day
? Thou art more lovely and more temperate: Rough winds do shake the
darling buds of May."
) rose 4.23% to top
(^GSPC), a day after the travel sector was boosted by Beijing
(OTCMKTS:CLMDY) for 700 million bucks. (Because the
Chinese make such exemplary tourists
.) All the tea in China was powerless to prevent
look like Hitler
, plunging 1.37% despite getting a price objective increase at
), which knows all about
tempests in teapots
No top-tier economic data due today, but
The Fresh Market
(TR) are all expected to release results.
(ALKS): Leerink launches the stock at Outperform.
Chicago Bridge & Iron Company
(CBI): The company is covered with a Neutral at Robert W. Baird,
whose price objective is $73. Robust energy-related end markets is
somewhat mitigated by recent stock strength, the broker believes.
(FMER): FMER is a fresh Overweight at JPMorgan.
(I): RBC Capital sets an Outperform on the satellite stock.
(MNTX): Benchmark begins a Buy rating and $14 target price on an
outfit it notes is often strongest in its second and third
Nuverra Environmental Solutions
(NES): NES is a new Buy at Needham, which assigns a $4.50 price
objective on an outfit it says has a nicely leveraged operating
model amid real promise in its gas assets.
): The recent initial public offering is a new Neutral at
Citigroup, Goldman Sachs, JPMorgan, Lazard Capital, and Nomura.
Bank of America-Merrill Lynch and KeyBanc are both more bullish,
beginning Buy-rated research, and Macquarie has an equally upbeat
(LNCE): The snack food stock is a new Neutral at Suntrust Robinson
(SPPI): Burrill starts an Outperform recommendation and $12 price
target on SPPI, a stock it says can garner future revenue from
Folotyn, Fusilev, and Zevalin.
Stock Upgrades: Athenahealth Is in Fine Fettle
Stock Downgrades: Javelin Mortgage Is a Falling